Obese women are at an increased risk of death from cervical cancer, but the explanation for
this is unknown. Through our systematic review, we sought to determine whether obesity is …

Background The human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine was
immunogenic, generally well tolerated, and effective against HPV-16 or HPV-18 infections …

Background Limited data are available describing human papillomavirus (HPV) genotype
distributions in cervical cancer in the United States. Such studies are needed to predict how …

Objective To evaluate the cumulative incidence of cervical intraepithelial neoplasia II or
worse (grade II+) or cervical intraepithelial neoplasia grade III+ after short term persistence …

The objective of the present paper is to summarize and quantify the trends in incidence and
mortality rates of cervical squamous cell carcinoma (SCC) and adenocarcinoma (AC) …

Current prophylactic HPV vaccines and gynecologic premaligna... : Current Opinion in
Obstetrics and Gynecology Current prophylactic HPV vaccines and gynecologic …

Integration of high-risk human papillomavirus (HPV) types into the host-cell genome disrupts
the HPV regulatory E2 protein, resulting in a loss of negative feedback control of viral …

Cervical cancer, a potentially preventable disease, remains the second most common
malignancy in women worldwide. Human papillomavirus is the single most important …

OBJECTIVE: Chlamydia trachomatis (Ct) has been implicated as a co-factor in cervical
carcinogenesis. The goal of the current study was to investigate if Ct may play a role in …

Purpose Although cervical squamous cell carcinoma (SCC) and adenocarcinoma (AC) are
both caused by human papillomavirus (HPV) infection, they differ in cofactors such as …